entrance 发表于 2025-3-30 10:34:19

http://reply.papertrans.cn/17/1640/163959/163959_51.png

heterogeneous 发表于 2025-3-30 13:50:26

Book 2005 p- portionofelderly people,especiallyinEuropeandNorthAmerica. Inaddition, the World Health Organization makes the alarming prediction that probably in response to the spreading of western dietary behavior and lack of exercise resulting in an increasing prevalence of diabetes, dyslipidemia and hyper

巨头 发表于 2025-3-30 19:15:09

0171-2004 kes the alarming prediction that probably in response to the spreading of western dietary behavior and lack of exercise resulting in an increasing prevalence of diabetes, dyslipidemia and hyper978-3-642-43897-4978-3-540-27661-6Series ISSN 0171-2004 Series E-ISSN 1865-0325

背景 发表于 2025-3-30 23:05:25

http://reply.papertrans.cn/17/1640/163959/163959_54.png

Eclampsia 发表于 2025-3-31 01:27:30

Metabolic Syndrome: Therapeutic Considerationsome deserve management in the clinical setting to reduce the risk for both ASCVD and type 2 diabetes. The two major therapeutic strategies for treatment of affected persons are modification of the underlying risk factors and separate drug treatment of the particular metabolic risk factors when appro

担心 发表于 2025-3-31 07:51:43

Physical Activity, Obesity and Cardiovascular Diseases the optimal approach in weight reduction programs appears to be a combination of regular physical activity and caloric restriction. A minimum of 60 min, but most likely 80–90 min of moderate-intensity physical activity per day may be needed to avoid or limit weight regain in formerly overweight or

cinder 发表于 2025-3-31 09:11:05

http://reply.papertrans.cn/17/1640/163959/163959_57.png

离开 发表于 2025-3-31 16:02:23

http://reply.papertrans.cn/17/1640/163959/163959_58.png

排斥 发表于 2025-3-31 20:06:14

http://reply.papertrans.cn/17/1640/163959/163959_59.png

Aromatic 发表于 2025-4-1 00:19:39

http://reply.papertrans.cn/17/1640/163959/163959_60.png
页: 1 2 3 4 5 [6] 7
查看完整版本: Titlebook: Atherosclerosis: Diet and Drugs; Arnold Eckardstein Book 2005 Springer-Verlag Berlin Heidelberg 2005 Angiotensin II.atherosclerosis.cardio